Benzinga | May 13, 2021 07:36AM EDT

InMed Pharmaceuticals Q3 EPS $(0.41) Down From $(0.39) YoY

InMed Pharmaceuticals (NASDAQ:INM) reported quarterly losses of $(0.41) per share. This is a 5.13 percent decrease over losses of $(0.39) per share from the same period last year.